Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN71,9471,952,98
Msft0,13
Nokia4,374,520,65
IBM-1,94
Mercedes-Benz Group AG50,9350,950,39
PFE-3,00
10.05.2025 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 09.05.2025 21:51:20
Natural Alt Intl (NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
3,23 1,89 0,06 7 844
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 11.05.2025
Popis společnosti
Obecné informace
Název společnostiNatural Alternatives International Inc
TickerNAII
Kmenové akcie:Ordinary Shares
RICNAII.O
ISIN-
Poslední známé roční výsledky30.06.2024
Poslední známé čtvrtletní výsledky31.12.2024
Počet zaměstnanců k 30.06.2024 296
Akcie v oběhu k 14.02.2025 6 198 778
MěnaUSD
Kontaktní informace
Ulice1535 Faraday Avenue
MěstoCARLSBAD
PSČ92008
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon17 607 367 700
Fax17607449589

Business Summary: Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. Its primary business activity is to provide private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbs, and other nutritional supplements, as well as other health care products, to consumers both within and outside the United States. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer ecommerce channels, and retail stores. It manufactures products in a variety of forms, including capsules, tablets, chewable wafers, and powders to accommodate a variety of its customer’s preferences. It also seeks to commercialize its patent and trademarks through the direct distribution and sale of CarnoSyn, SR CarnoSyn, TriBsyn, new contract manufacturing opportunities, and various license, royalty, and similar arrangements.
Financial Summary: BRIEF: For the six months ended 31 December 2024, Natural Alternatives International Inc revenues increased 14% to $67.2M. Net loss increased 11% to $4.2M. Revenues reflect Private Label Contract Manufacturing segment increase of 14% to $62.9M, Patent & trademark licensing segment increase of 9% to $4.3M, Outside USA segment increase of 47% to $25.8M.
Odvětvová klasifikace
TRBC2012Pharmaceuticals (NEC)
RBSS2004Pharmaceuticals - Generic & Specialty
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSMedicinal and Botanical Manufacturing
NAICSPharmaceutical Preparation Manufacturing
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
NAICS2007Medicinal & Botanical Mfg
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
NAICS1997Medicinal and Botanical Manufacturing
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Research and Development in the Physical, Engineering, and Life Sciences
SICMedicinals And Botanicals
SICMedicinals And Botanicals
SICPharmaceutical Preparations
SICCommercial Physical Research



  • Poslední aktualizace: 11.05.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board of Directors, Chief Executive OfficerMark Ledoux7028.09.2001
President, Chief Operating Officer, SecretaryKenneth Wolf6311.02.2008
Chief Financial OfficerMichael Fortin4701.10.2015